Targeted lysis of HIV-infected cells by natural killer cells armed and triggered by a recombinant immunoglobulin fusion protein: Implications for immunotherapy

Virology

Volumn 332, Issue 2, 2005, Pages 491-497

  Gupta, Neil ^a   Arthos, James ^a   Khazanie, Prateeti ^a   Steenbeke, Tavis D ^a   Censoplano, Nina M ^a   Chung, Eva A ^a   Cruz, Catherine C ^a   Chaikin, Margery A ^a   Daucher, Marybeth ^a   Kottilil, Shyam ^a   Mavilio, Domenico ^a   Schuck, Peter ^b   Sun, Peter D ^a   Rabin, Ronald L ^c   Radaev, Sergei ^a   Van Ryk, Donald ^a   Cicala, Claudia ^a   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Antibody dependent cellular cytotoxicity; CD16; HIV; Immunotherapy; Natural killer cell; Recombinant antibody

Indexed keywords

HYBRID PROTEIN; RECOMBINANT ANTIBODY;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; MOLECULAR MODEL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD; CALCIUM SIGNALING; CELL LINE, TUMOR; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN G; IMMUNOTHERAPY; KILLER CELLS, NATURAL; RECEPTORS, IGG;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 19944432210     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.12.018     Document Type: Article

References (26)

1. R. Ahmad, S.T. Sindhu, E. Toma, R. Morisset, J. Vincelette, J. Menezes, and A. Ahmad Evidence for a correlation between antibody-dependent cellular cytotoxicity-mediating anti-HIV-1 antibodies and prognostic predictors of HIV infection J. Clin. Immunol. 21 3 2001 227 233
2. J. Arthos, C. Cicala, T.D. Steenbeke, T.W. Chun, C. Dela Cruz, D.B. Hanback, P. Khazanie, D. Nam, P. Schuck, S.M. Selig, D. Van Ryk, M.A. Chaikin, and A.S. Fauci Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein: implications for therapeutic and vaccine strategies J. Biol. Chem. 277 13 2002 11456 11464
3. B.G. Brenner, A. Dascal, R.G. Margolese, and M.A. Wainberg Natural killer cell function in patients with acquired immunodeficiency syndrome and related diseases J. Leukocyte Biol. 46 1 1989 75 83
4. B.G. Brenner, C. Gryllis, M. Gornitsky, and M.A. Wainberg Changes in natural immunity during the course of HIV-1 infection Clin. Exp. Immunol. 93 2 1993 142 148
5. L.M. Cummins, K.J. Weinhold, T.J. Matthews, A.J. Langlois, C.F. Perno, R.M. Condie, and J.P. Allain Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors Blood 77 5 1991 1111 1117
6. E. Derby, V. Reddy, W. Kopp, E. Nelson, M. Baseler, T. Sayers, and A. Malyguine Three-color flow cytometric assay for the study of the mechanisms of cell-mediated cytotoxicity Immunol. Lett. 78 1 2001 35 39
7. S.S. Farag, T.A. Fehniger, L. Ruggeri, A. Velardi, and M.A. Caligiuri Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect Blood 100 6 2002 1935 1947
8. P.D. Kwong, M.L. Doyle, D.J. Casper, C. Cicala, S.A. Leavitt, S. Majeed, T.D. Steenbeke, M. Venturi, I. Chaiken, M. Fung, H. Katinger, P.W. Parren, J. Robinson, D. Van Ryk, L. Wang, D.R. Burton, E. Freire, R. Wyatt, J. Sodroski, W.A. Hendrickson, and J. Arthos HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites Nature 420 6916 2002 678 682
9. J. Lebowitz, M.S. Lewis, and P. Schuck Modern analytical ultracentrifugation in protein science: a tutorial review Protein Sci. 11 9 2002 2067 2079
10. M. Purtscher, A. Trkola, A. Grassauer, P.M. Schulz, A. Klima, S. Dopper, G. Gruber, A. Buchacher, T. Muster, and H. Katinger Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5 Aids 10 6 1996 587 593
11. S. Radaev, and P. Sun Recognition of immunoglobulins by Fc gamma receptors Mol. Immunol. 38 14 2002 1073 1083
12. S. Radaev, S. Motyka, W.H. Fridman, C. Sautes-Fridman, and P.D. Sun The structure of a human type III Fc gamma receptor in complex with Fc J. Biol. Chem. 276 19 2001 16469 16477
13. Y. Riviere, F. Tanneau-Salvadori, A. Regnault, O. Lopez, P. Sansonetti, B. Guy, M.P. Kieny, J.J. Fournel, and L. Montagnier Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins J. Virol. 63 5 1989 2270 2277
14. L. Ruggeri, M. Capanni, E. Urbani, K. Perruccio, W.D. Shlomchik, A. Tosti, S. Posati, D. Rogaia, F. Frassoni, F. Aversa, M.F. Martelli, and A. Velardi Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science 295 5562 2002 2097 2100
15. P. Schuck Sedimentation analysis of noninteracting and self-associating solutes using numerical solutions to the Lamm equation Biophys. J. 75 3 1998 1503 1512
16. P. Schuck, and P. Rossmanith Determination of the sedimentation coefficient distribution by least-squares boundary modeling Biopolymers 54 5 2000 328 341
17. M.E. Sheehy, A.B. McDermott, S.N. Furlan, P. Klenerman, and D.F. Nixon A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis J. Immunol. Methods 249 1-2 2001 99 110
18. R.I. Smith, M.J. Coloma, and S.L. Morrison Addition of a mu-tailpiece to IgG results in polymeric antibodies with enhanced effector functions including complement-mediated cytolysis by IgG4 J. Immunol. 154 5 1995 2226 2236
19. F. Tanneau, M. McChesney, O. Lopez, P. Sansonetti, L. Montagnier, and Y. Riviere Primary cytotoxicity against the envelope glycoprotein of human immunodeficiency virus-1: evidence for antibody-dependent cellular cytotoxicity in vivo J. Infect. Dis. 162 4 1990 837 843
20. A. Trkola, M. Purtscher, T. Muster, C. Ballaun, A. Buchacher, N. Sullivan, K. Srinivasan, J. Sodroski, J.P. Moore, and H. Katinger Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 J. Virol. 70 2 1996 1100 1108
21. D.S. Tyler, C.L. Nastala, S.D. Stanley, T.J. Matthews, H.K. Lyerly, D.P. Bolognesi, and K.J. Weinhold GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody J. Immunol. 142 4 1989 1177 1182
22. D.S. Tyler, S.D. Stanley, S. Zolla-Pazner, M.K. Gorny, P.P. Shadduck, A.J. Langlois, T.J. Matthews, D.P. Bolognesi, T.J. Palker, and K.J. Weinhold Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies J. Immunol. 145 10 1990 3276 3282
23. K.J. Weinhold, H.K. Lyerly, T.J. Matthews, D.S. Tyler, P.M. Ahearne, K.C. Stine, A.J. Langlois, D.T. Durack, and D.P. Bolognesi Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals Lancet 1 8591 1988 902 905
24. K.J. Weinhold, D.S. Tyler, and H.K. Lyerly Measurement of direct and indirect forms of anti-HIV-1 ADCC: implications for other retroviral disease Dev. Biol. Stand. 72 1990 343 348
25. D. Weissman, R.L. Rabin, J. Arthos, A. Rubbert, M. Dybul, R. Swofford, S. Venkatesan, J.M. Farber, and A.S. Fauci Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor Nature 389 6654 1997 981 985
26. K.P. Windebank, R.T. Abraham, G. Powis, R.A. Olsen, T.J. Barna, and P.J. Leibson Signal transduction during human natural killer cell activation: inositol phosphate generation and regulation by cyclic AMP J. Immunol. 141 11 1988 3951 3957